Home › Funds › Invenomic Capital Management LP › BDX

Invenomic Capital Management LP position in BDX

BECTON DICKINSON & CO · Health Care

Invenomic Capital Management LP reported holding 273,182 shares of BDX (BECTON DICKINSON & CO) in its Q2 2026 13F filing — a position valued at US$41.3M, representing 2.47% of its reported portfolio and ranking #7 among its reported holdings. Invenomic Capital Management LP first reported this position in Q2 2026.

Latest position (Q2 2026)273.18K sh
Reported value held$41.34M
Portfolio Weight2.47%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's BDX position evolved

Invenomic Capital Management LP first disclosed a stake in BDX in Q2 2026 at 273,182 shares (US$41.3M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 273.18K $41.34M New

About BDX and 13F data

BDX (BECTON DICKINSON & CO) is a Health Care company. 18 other funds we track also report a position in BDX — the largest reported positions include MFS Investment Management (US$2.48B), First Eagle Investment Management (US$2.09B), GREENHAVEN ASSOCIATES INC (US$859.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BDX

All BDX fund holders →

FAQ

How long has Invenomic Capital Management LP held BDX?

Invenomic Capital Management LP has disclosed BDX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Invenomic Capital Management LP's current position in BDX?

As of Q2 2026, Invenomic Capital Management LP holds 273.18K shares of BDX (BECTON DICKINSON & CO), valued at $41.34M, representing 2.47% of its reported portfolio and ranking #7.

Has Invenomic Capital Management LP been buying or selling BDX?

In the latest 13F filing (Q2 2026), Invenomic Capital Management LP newly opened its position in BDX.

Which other funds hold BDX?

Other major institutional holders of BDX include MFS Investment Management, First Eagle Investment Management, GREENHAVEN ASSOCIATES INC, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.